Viewing Study NCT02846935


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-01-02 @ 10:22 PM
Study NCT ID: NCT02846935
Status: COMPLETED
Last Update Posted: 2019-01-07
First Post: 2016-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
Sponsor: Yogen Saunthararajah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module